GLP-1 vs. GLP-3:

Everything You Need to Know

The peptide landscape is evolving fast. Here's your no-fluff guide to understanding the difference — and finding the right fit for your goals.

Doll Haus Aesthetics  ·  Wellness Series

By now, you've probably heard of Ozempic. Maybe even Mounjaro. But the conversation has quickly grown beyond a single medication — and if you're feeling confused by terms like GLP-1, GLP-2, GLP-3, semaglutide, and tirzepatide, you are not alone. Let's break it all down, clearly and honestly.

What Are Glucagon-Like Peptides?

GLP stands for Glucagon-Like Peptide — a family of hormones your body naturally produces in the gut when you eat. They play a critical role in regulating blood sugar, appetite, digestion, and metabolism. When pharmaceutical researchers discovered they could mimic these hormones with medications, it opened the door to an entirely new class of treatments for diabetes and weight management.

All three peptides — GLP-1, GLP-2, and what's being colloquially called "GLP-3" — actually originate from the same genetic source (a precursor molecule called proglucagon) but are processed differently depending on where in the body they're activated: the pancreas, intestines, or brain.

Quick Clarity

GLP-1, GLP-2, and GLP-3 are not separate drugs — they're categories describing how many hormonal pathways a medication targets. The more receptors activated, generally the broader the metabolic effect.

GLP-1: The Original

GLP-1 (glucagon-like peptide-1) is the hormone that started it all. It's naturally released from specialized cells in your small intestine after eating and does several important things: it signals your pancreas to release insulin, tells your liver to slow glucose production, and sends satiety signals to your brain — essentially telling you that you're full.

GLP-1 receptor agonist medications work by mimicking this hormone. They were originally developed to treat type 2 diabetes, but their appetite-suppressing effects made them powerful tools for weight management as well.

FDA-Approved GLP-1 Medications

Semaglutide

Ozempic / Wegovy / Rybelsus

Currently the most widely used GLP-1. Ozempic and Wegovy are weekly injections; Rybelsus is an oral pill. Wegovy is approved specifically for weight loss, while Ozempic is approved for type 2 diabetes (though often used off-label for weight). Clinical data shows average body weight reductions of around 15–21% depending on dose.

Liraglutide

Victoza / Saxenda

A once-daily injection and the predecessor to semaglutide. It paved the way for the modern GLP-1 era. Saxenda is FDA-approved for weight management; Victoza is approved for type 2 diabetes. Effective but requires daily dosing and produces more modest weight loss than semaglutide.

Dulaglutide

Trulicity

A once-weekly injection approved for type 2 diabetes. Less commonly used for weight loss but still effective for blood sugar management with some appetite-suppressing benefits.

Exenatide

Byetta / Bydureon

One of the earliest GLP-1 medications, now largely overshadowed by newer options. Byetta requires twice-daily dosing; Bydureon is once weekly. Both have more moderate efficacy compared to newer medications.

GLP-2: The Gut Healer

GLP-2 tends to get overlooked in the weight loss conversation — and for good reason. It works very differently. GLP-2 primarily supports the health and integrity of the intestinal lining. It promotes gut repair, reduces inflammation, and improves nutrient absorption. It doesn't directly suppress appetite or drive weight loss the way GLP-1 does.

GLP-2 medications exist (teduglutide, or Gattex, is one example) but they're approved for very specific digestive conditions like short bowel syndrome — not weight management. For our purposes here, just know that GLP-2 exists, it's different, and it's not what most people are asking about when they say "GLP" in a wellness context.

GLP-3: The Next Generation

Here's where it gets interesting — and where a bit of terminology cleanup is needed. "GLP-3" isn't technically an official medical classification the way GLP-1 and GLP-2 are. In popular wellness and media conversations, GLP-3 has become shorthand for a new class of triple agonist medications that activate not one, but three distinct hormonal receptors simultaneously.

Think of it this way: if GLP-1 drugs flip one metabolic switch, and dual agonists (like tirzepatide) flip two, then triple agonists flip three — targeting GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor all at once. More pathways activated means broader metabolic signaling, faster energy expenditure, and more significant results.

GLP-1 vs. Dual vs. Triple: A Clear Comparison

Single Agonist

GLP-1

Activates one receptor. Regulates appetite and blood sugar. Examples: semaglutide (Ozempic, Wegovy). Well-established safety profile with 7+ years of data.

Dual Agonist

GLP-1 + GIP

Activates two receptors. More effective for weight loss than single agonists. Example: tirzepatide (Mounjaro, Zepbound). Average 22.5% body weight reduction in trials.

Triple Agonist ("GLP-3")

GLP-1 + GIP + Glucagon

Activates three receptors including glucagon, which increases energy expenditure. Example: retatrutide. Trials showed up to 24–28% weight loss. Still in FDA review as of 2026.

Tirzepatide: Currently the Most Powerful Available Option

Tirzepatide (brand names Mounjaro for diabetes and Zepbound for weight management) is currently the gold standard in terms of weight loss efficacy among approved medications. It works on both the GLP-1 and GIP receptors, giving it a broader reach than semaglutide alone.

In head-to-head clinical trials published in 2025, tirzepatide produced significantly greater reductions in body weight compared to semaglutide over 72 weeks. On average, patients saw about 22.5% body weight reduction — a number that was previously only seen with bariatric surgery.

By the Numbers

A 2024 meta-analysis of 53 studies found tirzepatide led to the greatest weight loss of all GLP-1 class drugs, followed by semaglutide, then liraglutide. High-dose semaglutide (7.2 mg injection) trials have also shown around 21% body weight reduction after 72 weeks.

Retatrutide: The "GLP-3" on the Horizon

Retatrutide (developed by Eli Lilly) is the emerging triple agonist that has the wellness and medical communities most excited. By targeting GLP-1, GIP, and glucagon receptors simultaneously, it doesn't just suppress appetite — it also increases how much energy your body burns at rest, addressing metabolism from multiple angles at once.

In clinical trials, participants on the highest dose of retatrutide lost an average of 36+ pounds over 40 weeks, with overall weight reductions of 24–28% in longer studies. Those are remarkable numbers. The glucagon receptor activation is the key differentiator — it increases metabolic rate in a way that single or dual agonists can't fully replicate.

As of 2026, retatrutide is still undergoing FDA review. It has not yet been approved for public use, though it is expected to be a significant market entrant when it does arrive.

How to Choose the Right One for You

There's no single "best" option — the right GLP medication depends on your health history, goals, and what your prescribing provider recommends. Here are the key factors to consider:

1

Your primary goal For weight loss alone: Wegovy (semaglutide) or Zepbound (tirzepatide) are the two FDA-approved options. For blood sugar management alongside weight loss, Ozempic or Mounjaro may be more appropriate.

2

How much weight you need to loseIf you have a significant amount to lose, tirzepatide's higher efficacy may make it the more appropriate choice. If you're earlier in your journey or more sensitive to side effects, semaglutide's longer track record may feel safer.

3

Injection vs. oral Discomfort with injections? Rybelsus (oral semaglutide) and a newer oral option, Foundayo, are available. Note that oral GLP-1s require specific timing with food and water to absorb properly.

4

Side effect tolerance All GLP-1 class medications share similar gastrointestinal side effects — nausea, vomiting, diarrhea — especially during dose escalation. Tirzepatide tends to cause slightly more GI distress than semaglutide. Starting low and titrating slowly helps.

5

Cost and insurance coverage Without insurance, most GLP-1 medications run $900–$1,400/month. Many insurance plans cover these for diabetes but not weight management specifically. Always check your coverage and ask your provider about manufacturer discount programs.

6

Pairing with body treatments GLP medications address fat reduction systemically, but body contouring treatments like RF skin tightening, laser lipo, and ultrasonic cavitation can complement your results — especially for skin laxity as weight decreases.

Important note: This article is for educational purposes only and is not medical advice. GLP-1 and GLP-3 class medications require a prescription from a licensed medical provider. Always consult a physician or nurse practitioner before starting, stopping, or changing any medication. Doll Haus Aesthetics does not prescribe medications. We are here to support your wellness journey through body treatments and education.

The Bottom Line

The GLP landscape is evolving at an extraordinary pace. What was a single-drug conversation a few years ago has become a rich, nuanced category with meaningfully different options at every level. GLP-1 medications like semaglutide are proven, accessible, and well-studied. Dual agonists like tirzepatide are currently the most effective FDA-approved option. And triple agonists like retatrutide represent an exciting frontier — not quite here yet, but coming.

The best thing you can do right now is educate yourself, work with a qualified medical provider, and build a holistic approach to your body goals — one that includes not just medication but movement, nutrition, skin health, and targeted body treatments that support your results from the outside in.

Ready to Elevate Your Results?

RF skin tightening, laser lipo, lymphatic drainage, and body contouring work beautifully alongside your wellness journey. Book your personalized consultation at Doll Haus Aesthetics.